Caricamento...
Dornase alfa for cystic fibrosis
BACKGROUND: Dornase alfa is currently used as a mucolytic to treat pulmonary disease (the major cause of morbidity and mortality) in cystic fibrosis. It reduces mucus viscosity in the lungs, promoting improved clearance of secretions. This is an update of a previously published review. OBJECTIVES: T...
Salvato in:
| Pubblicato in: | Cochrane Database Syst Rev |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Ltd
2018
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513278/ https://ncbi.nlm.nih.gov/pubmed/30187450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001127.pub4 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|